Micro-X Limited (MX1.AX)
AUD 0.08
(7.79%)
AUD 0.08
(7.79%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | 826.99 Thousand AUD | 267.47% |
| 2023 | -455 Thousand AUD | 90.76% |
| 2022 | -4.92 Million AUD | 79.68% |
| 2021 | -24.23 Million AUD | -407.71% |
| 2020 | -4.77 Million AUD | -141.89% |
| 2019 | 11.39 Million AUD | 105.97% |
| 2018 | 5.53 Million AUD | 315.0% |
| 2017 | -2.57 Million AUD | 38.28% |
| 2016 | -4.16 Million AUD | 5.77% |
| 2015 | -4.42 Million AUD | -2347.3% |
| 2014 | 196.88 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -905 Thousand AUD | 0.0% |
| 2024 Q4 | 826.99 Thousand AUD | 0.0% |
| 2024 FY | 826.99 Thousand AUD | 281.76% |
| 2023 FY | -455 Thousand AUD | 90.76% |
| 2023 Q4 | -455 Thousand AUD | 0.0% |
| 2023 Q2 | -6.35 Million AUD | 0.0% |
| 2022 Q4 | -4.92 Million AUD | 0.0% |
| 2022 FY | -4.92 Million AUD | 79.68% |
| 2022 Q2 | -14.3 Million AUD | 0.0% |
| 2021 FY | -24.23 Million AUD | -407.71% |
| 2021 Q4 | -24.23 Million AUD | 0.0% |
| 2021 Q2 | 1.06 Million AUD | 0.0% |
| 2020 Q2 | 277 Thousand AUD | 0.0% |
| 2020 FY | -4.77 Million AUD | -141.89% |
| 2020 Q4 | -4.77 Million AUD | 0.0% |
| 2019 Q2 | 2.37 Million AUD | 0.0% |
| 2019 Q4 | 11.39 Million AUD | 0.0% |
| 2019 FY | 11.39 Million AUD | 105.97% |
| 2018 Q2 | -1.09 Million AUD | 0.0% |
| 2018 FY | 5.53 Million AUD | 315.0% |
| 2018 Q4 | 5.53 Million AUD | 0.0% |
| 2017 Q2 | -2.8 Million AUD | 0.0% |
| 2017 Q4 | -2.57 Million AUD | 0.0% |
| 2017 FY | -2.57 Million AUD | 38.28% |
| 2016 Q4 | -4.16 Million AUD | 0.0% |
| 2016 Q2 | -18.36 Million AUD | 0.0% |
| 2016 FY | -4.16 Million AUD | 5.77% |
| 2015 Q4 | 12.82 Million AUD | 594.64% |
| 2015 FY | -4.42 Million AUD | -2347.3% |
| 2015 Q3 | -2.59 Million AUD | 0.0% |
| 2014 FY | 196.88 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| 4DMedical Limited | -25.48 Million AUD | 103.245% |
| Adherium Limited | -6.1 Million AUD | 113.548% |
| Aroa Biosurgery Limited | -3.74 Million AUD | 122.07% |
| Atomo Diagnostics Limited | -3.6 Million AUD | 122.951% |
| Anteris Technologies Ltd | -28.49 Million AUD | 102.902% |
| Control Bionics Limited | -19.02 Thousand AUD | 4447.592% |
| CardieX Limited | 2.74 Million AUD | 69.887% |
| Compumedics Limited | 5.08 Million AUD | 83.743% |
| Cochlear Limited | -269.9 Million AUD | 100.306% |
| CleanSpace Holdings Limited | 698.59 Thousand AUD | -18.381% |
| Cyclopharm Limited | -7.49 Million AUD | 111.028% |
| EMVision Medical Devices Ltd | -15.7 Million AUD | 105.267% |
| Nova Eye Medical Limited | -2.8 Million AUD | 129.515% |
| HeraMED Limited | -799.34 Thousand AUD | 203.459% |
| Imricor Medical Systems, Inc. | 14.48 Million AUD | 94.29% |
| ImpediMed Limited | -23.48 Million AUD | 103.521% |
| InhaleRx Limited | -155.54 Thousand AUD | 631.682% |
| LBT Innovations Limited | -604 Thousand AUD | 236.92% |
| Neurotech International Limited | -2.11 Million AUD | 139.185% |
| OncoSil Medical Limited | -4.43 Million AUD | 118.665% |
| PolyNovo Limited | -30.52 Million AUD | 102.709% |
| Respiri Limited | 413.68 Thousand AUD | -99.908% |
| SomnoMed Limited | -15.16 Million AUD | 105.454% |
| Universal Biosensors, Inc. | -5.3 Million AUD | 115.592% |
| Uscom Limited | -1.53 Million AUD | 154.03% |
| Visioneering Technologies, Inc. | -4.08 Million AUD | 120.255% |